Changes in Stockholders' Equity

6 Months Ended

Jun. 30, 2025

Changes in Stockholders' Equity

Changes in Stockholders' Equity

(3) Changes in Stockholders’ Equity

Three and Six Months Ended June 30, 2025 and 2024 (in thousands):


											Accumulated
								Additional			Other						Total
		Common Stock						Paid-In			Comprehensive			Accumulated			Stockholders’
		Shares		Amount				Capital			Income (loss)			Deficit			Equity
Balance, March 31, 2025		286,975		$	29		$	719,315		$	(88)		$	(512,128)		$	207,128
Issuance of common stock upon exercise of stock options		1,297			—			1,116			—			—			1,116
Issuance of common stock upon exercise of common stock warrants		10			—			67			—			—			67
Issuance of common stock upon release of restricted stock units ("RSUs")		2,150			—			—			—			—			—
Proceeds from sale of common stock from Quanta private placement transaction		3,020			—			35,000			—			—			35,000
Proceeds from sale of common stock through At-The-Market ("ATM") Offering		30,310			3			346,716			—			—			346,719
Capitalization of offering costs to equity upon share issuance		—			—			(888)			—			—			(888)
Stock-based compensation		—			—			3,554			—			—			3,554
Foreign currency translation gain		—			—			—			156			—			156
Change in unrealized gain on available-for-sale securities		—			—			—			65			—			65
Net loss		—			—			—			—			(39,654)			(39,654)
Balance, June 30, 2025		323,762		$	32		$	1,104,880		$	133		$	(551,782)		$	553,263


										Accumulated
							Additional			Other						Total
		Common Stock					Paid-In			Comprehensive			Accumulated			Stockholders’
		Shares		Amount			Capital			Income			Deficit			Equity
Balance, December 31, 2024		283,547		$	29		$	681,202		$	105		$	(554,747)		$	126,589
Issuance of common stock upon exercise of stock options		1,595			—			1,443			—			—			1,443
Issuance of common stock upon exercise of common stock warrants		56			—			733			—			—			733
Issuance of common stock upon release of RSUs		5,234			—			—			—			—			—
Proceeds from sale of common stock from Quanta private placement transaction		3,020			—			35,000			—			—			35,000
Proceeds from sale of common stock through ATM Offering		30,310			3			346,716			—			—			346,719
Vesting of Promote Sponsor Vesting Shares		—			—			32,946			—			—			32,946
Capitalization of offering costs to equity upon share issuance		—			—			(888)			—			—			(888)
Stock-based compensation		—			—			7,728			—			—			7,728
Foreign currency translation loss		—			—			—			(29)			—			(29)
Change in unrealized gain on available-for-sale securities		—			—			—			57			—			57
Net income		—			—			—			—			2,965			2,965
Balance, June 30, 2025		323,762		$	32		$	1,104,880		$	133		$	(551,782)		$	553,263


										Accumulated
							Additional			Other						Total
		Common Stock					Paid-In			Comprehensive			Accumulated			Stockholders’
		Shares		Amount			Capital			Income			Deficit			Equity
Balance, March 31, 2024		165,311		$	16		$	489,955		$	138		$	(374,532)		$	115,577
Issuance of common stock upon exercise of stock options		31			—			8			—			—			8
Issuance of common stock upon release of RSUs		1,478			—			—			—			—			—
Proceeds from sale of common stock through ATM Offering		12,777			1			15,801			—			—			15,802
Capitalization of deferred offering costs to equity upon share issuance		—			—			(80)			—			—			(80)
Stock-based compensation		—			—			3,287			—			—			3,287
Foreign currency translation loss		—			—			—			(17)			—			(17)
Change in unrealized loss on available-for-sale securities		—			—			—			2			—			2
Net loss		—			—			—			—			(12,421)			(12,421)
Balance, June 30, 2024		179,597		$	17		$	508,971		$	123		$	(386,953)		$	122,158


										Accumulated
							Additional			Other						Total
		Common Stock					Paid-In			Comprehensive			Accumulated			Stockholders’
		Shares		Amount			Capital			Income			Deficit			Equity
Balance, December 31, 2023		147,066		$	14		$	463,089		$	244		$	(353,759)		$	109,588
Issuance of common stock upon exercise of stock options		250			—			68			—			—			68
Issuance of common stock upon release of RSUs		2,801			—			—			—			—			—
Proceeds from sale of common stock through Purchase Agreement - B. Riley		10,057			1			12,837			—			—			12,838
Proceeds from sale of common stock through ATM Offering		19,423			2			26,831			—			—			26,833
Capitalization of deferred offering costs to equity upon share issuance		—			—			(132)			—			—			(132)
Stock-based compensation		—			—			6,278			—			—			6,278
Foreign currency translation loss		—			—			—			(105)			—			(105)
Change in unrealized loss on available-for-sale securities		—			—			—			(16)			—			(16)
Net loss		—			—			—			—			(33,194)			(33,194)
Balance, June 30, 2024		179,597		$	17		$	508,971		$	123		$	(386,953)		$	122,158